The COVID-19 impact on severe uncontrolled asthma costs and biologic use. Khan NS, Rubin E, McKenna B, Palowitch BL, et al. Allergy Asthma Proc 2023;44:340-344.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Khan NS, Rubin E, McKenna B, Palowitch BL, et al. The COVID-19 impact on severe uncontrolled asthma costs and biologic use. Allergy Asthma Proc 2023;44:340-344.
PMID: 37641228